Table 6.
Evolution of patients on anticholinergic combination therapy
| Type of bladder dysfunction | Still on combination, dosage | Stopped 1 or both medications | Total | |||||
|---|---|---|---|---|---|---|---|---|
| Stable | ↑ | ↓ | Dry | S/E | Botox | Augment | ||
| Neurogenic | 12 | 1 | 1 | 1 | 2 | 7 | 1 | 25 |
| Non-neurogenic | 20 | 2 | 0 | 9 | 0 | 0 | 0 | 31 |
| All | 32 | 3 | 1 | 10 | 2 | 7 | 1 | 56 |
↑
Dose increasing;
↓
Dose tapering; S/E: Combination stopped because of side effects; Botox: intravesical injection of botulinum toxin; Augment: medications were discontinued and the patient underwent an augmentation enterocystoplasty.